Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration

October 29, 2018
Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma

Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …

Vaccine coverage falls by 6.2% since last year

October 29, 2018
Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines

Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …

shutterstock_273326141

Pfizer and Novartis partner up to develop combo therapies for NASH

October 29, 2018
Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma

Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …

HHS Secretary Alex Azar responds to pharma sector’s criticism over Medicare pricing plan

October 29, 2018
Sales and Marketing

US Health and Human Services (HHS) Secretary Alex Azar responded to industry criticism on Friday after big pharma warned that …

donald_trump_8567813820_2

President Trump unveils new plans to bring US drug prices in line with the rest of the world

October 26, 2018
Medical Communications, Sales and Marketing Drug pricing, Trump, US, pharma

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

October 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …

indian_flag

India declares Sterling Biotech owners ‘Economic Fugitives’

October 26, 2018
Medical Communications India, Modi, Sandesara, Sterling Biotech, corruption

India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new powers …

NICE issues draft guidance rejecting Abbvie’s Venclyxto in chronic lymphocytic leukaemia

October 26, 2018
Medical Communications, Sales and Marketing AbbVie, NHS, NICE, leukaemia, pharma, venetoclax

It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …

Magic mushroom ingredient psilocybin gains breakthrough therapy designation

October 26, 2018
Medical Communications Breakthrough Therapy Designation, Compass, FDA, Magic mushrooms, psylicobin

The US Food and Drug Administration (FDA) has given psilocybin – the psychoactive ingredient in ‘magic mushrooms’ – breakthrough therapy …

gsk_china_2_2_0_1

GSK opens £54m API plant in Montrose, Scotland

October 25, 2018
Manufacturing and Production API, GSK, Scotland, manufacturing, montrose

British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines. The new facility …

amgen_hq

Amgen slashes price of cholesterol drug Repatha by 60%

October 25, 2018
Sales and Marketing Repatha, cholestrol, drug, medicine, pricing

American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%. The …

FDA generics approvals up 90% compared to 2014

October 25, 2018
Sales and Marketing FDA, Trump, generics, pharma

Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic …

Measles outbreak threatens to decimate isolated Amazonian tribe in Venezuela and Brazil

October 25, 2018
Medical Communications Brazil, Venezuela, measles, tribe, vaccines, yanomami

An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International. …

flu

First novel, single-dose flu drug approved in US in almost 20 years

October 25, 2018
Sales and Marketing FDA, Shionogi, Xofluza, flu, influenza, pharma

The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in …

shutterstock_292920209

UCB and Biogen’s lupus drug falls short at Phase 2b

October 24, 2018
Research and Development Biogen, Lupus, UCB, dapirolizumab pegol, pharma, systemic lupus erythematosus, trial falure

The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet …

acute_lymphoblastic_leukaemia_smear

New $2 million programme aims at increasing diversity in cancer research

October 24, 2018
Research and Development Cancer, USA, black, cancer research, diversity, latino, native american

The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the …

shutterstock_360472550

Pfizer & Lilly’s non-opioid drug reduces pain in osteoarthritis

October 24, 2018
Research and Development Eli Lilly, Pfizer, osteoarthritis, pharma

Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of …

28246711066_52e38bc591_z

Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit

October 24, 2018
Research and Development brexit, no-deal Brexit, stockpiling

Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …

tibet-3591529_960_720

Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan

October 23, 2018
Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health

Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …

roche

Roche’s Alecensa topples Pfizer’s Xalkori in Asian patients with ALK+ advanced lung cancer

October 23, 2018
Manufacturing and Production, Research and Development Alecensa, Cancer, ESMO 2018, Roche, lung cancer, pharma

Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small …

The Gateway to Local Adoption Series

Latest content